# RePharm LLC – FDA Inspection, Nov 15, 2023

Source: https://www.keypedia.com/records/fda_inspections/repharm-llc/d956da1e-9a08-4d15-acab-0d5131399560
Source feed: FDA_Inspections

> FDA inspection 1224274 of RePharm LLC, November 15, 2023. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 2 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1224274
- Company Name: RePharm LLC
- Inspection Date: 2023-11-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1145918 - 2021-06-25](https://www.keypedia.com/records/fda_inspections/repharm-llc/d1db2e42-ffe7-44df-afa3-15cd465cca82)
- [FDA Inspection 1095778 - 2019-07-03](https://www.keypedia.com/records/fda_inspections/repharm-llc/0976a25f-4524-479d-bdea-a9895ac824d8)

## Related Officers

- [Issuing Officer](https://www.keypedia.com/people/gretchen-l-trendel/4de8009a-85c5-4a1c-a6c8-53b110b19bee)

Company: https://www.keypedia.com/companies/repharm-llc/d39558e4-a44b-43c5-b75c-563dee1dd778

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c